Concorde Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-6,758
Closed -$372K 132
2016
Q2
$372K Sell
6,758
-181
-3% -$9.63K 0.37% 66
2016
Q1
$350K Buy
6,939
+564
+9% +$27.6K 0.4% 65
2015
Q4
$322K Buy
6,375
+396
+7% +$20K 0.36% 71
2015
Q3
$282K Buy
+5,979
New +$318K 0.48% 71

Other funds holding MRK

Concorde Asset Management's MRK Position: Q3 2016 in Review

Concorde Asset Management sold out of Merck (MRK) in Q3 2016, closing a stake of 6,758 shares — an estimated $372K sold.

Concorde Asset Management first reported a position in MRK in Q3 2015 and held it in 4 quarters. The position peaked at $372K in Q2 2016. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

  • Concorde Asset Management reported no remaining Merck position as of Q3 2016 after selling out during the quarter.
  • Concorde Asset Management sold 6,758 Merck shares in Q3 2016, an estimated $372K.
  • Concorde Asset Management first reported a position in Merck in Q3 2015 and held it in 4 quarters.
  • Concorde Asset Management's Merck position peaked at $372K in Q2 2016.
  • 1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Concorde Asset Management's 13F filing for Q3 2016, filed 31 Oct 2016.